$ALGN
ALIGN TECHNOLOGY INC Stock $algn

$algn Overview Financials Valuation SEC Filings Company Website

2018 Q1 Form 10-Q Financial Statement

#000109714918000019 Filed on May 03, 2018

Income Statement

Concept	2018 Q1	2017 Q1
Revenue	$436.9M	$310.3M
YoY Change	40.79%	30.0%
Cost Of Revenue	$109.5M	$74.72M
YoY Change	46.58%	28.61%
Gross Profit	$327.4M	$235.6M
YoY Change	38.95%	30.45%
Gross Profit Margin	74.93%	75.92%
Selling, General & Admin	$199.6M	$151.1M
YoY Change	32.07%	34.7%
% of Gross Profit	60.97%	64.15%
Research & Development	$29.59M	$22.80M
YoY Change	29.76%	51.19%
% of Gross Profit	9.04%	9.68%
Depreciation & Amortization	$11.43M	$7.867M
YoY Change	45.34%	64.17%
% of Gross Profit	3.49%	3.34%
Operating Expenses	$229.2M	$174.0M
YoY Change	31.77%	36.65%
Operating Profit	$98.19M	$61.67M
YoY Change	59.21%	15.64%
Interest Expense	$2.200M	$1.600M
YoY Change	37.5%	-500.0%
% of Operating Profit	2.24%	2.59%
Other Income/Expense, Net	$177.0K	$450.0K
YoY Change	-60.67%	-205.39%
Pretax Income	$100.5M	$63.32M
YoY Change	58.79%	19.68%
Income Tax	$2.900M	-$7.223M
% Of Pretax Income	2.88%	-11.41%
Net Earnings	$95.87M	$69.42M
YoY Change	38.1%	71.21%
Net Earnings / Revenue	21.94%	22.37%
Basic Earnings Per Share	$1.20	$0.87
Diluted Earnings Per Share	$1.17	$0.85
COMMON SHARES
Basic Shares Outstanding	80.04M shares	79.90M shares
Diluted Shares Outstanding	81.63M shares	81.53M shares

Balance Sheet

Concept	2018 Q1	2017 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$662.7M	$545.6M
YoY Change	21.47%	-0.45%
Cash & Equivalents	$498.0M	$261.0M
Short-Term Investments	$164.7M	$284.6M
Other Short-Term Assets	$108.7M	$70.30M
YoY Change	54.62%	104.96%
Inventory	$35.87M	$35.17M
Prepaid Expenses
Receivables	$361.5M	$267.1M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$1.169B	$918.2M
YoY Change	27.29%	17.26%
LONG-TERM ASSETS
Property, Plant & Equipment	$400.5M	$231.7M
YoY Change	72.87%	56.52%
Goodwill		$92.45M
YoY Change		17.61%
Intangibles
YoY Change
Long-Term Investments	$52.80M	$43.94M
YoY Change	20.16%	-66.89%
Other Assets	$17.23M	$14.41M
YoY Change	19.63%	86.96%
Total Long-Term Assets	$614.0M	$541.1M
YoY Change	13.46%	27.46%
TOTAL ASSETS
Total Short-Term Assets	$1.169B	$918.2M
Total Long-Term Assets	$614.0M	$541.1M
Total Assets	$1.783B	$1.459B
YoY Change	22.16%	20.85%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$41.88M	$37.03M
YoY Change	13.11%	2.12%
Accrued Expenses	$180.1M	$125.6M
YoY Change	43.35%	35.49%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$518.0M	$365.6M
YoY Change	41.7%	33.05%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$17.94M	$2.542M
YoY Change	605.63%	68.23%
Total Long-Term Liabilities	$17.94M	$2.542M
YoY Change	605.63%	68.23%
TOTAL LIABILITIES
Total Short-Term Liabilities	$518.0M	$365.6M
Total Long-Term Liabilities	$17.94M	$2.542M
Total Liabilities	$655.3M	$414.4M
YoY Change	58.12%	31.34%
SHAREHOLDERS EQUITY
Retained Earnings	$267.3M	$196.2M
YoY Change	36.29%	188.73%
Common Stock	$8.000K	$8.000K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.127B	$1.045B
YoY Change
Total Liabilities & Shareholders Equity	$1.783B	$1.459B
YoY Change	22.16%	20.85%

Cashflow Statement

Concept	2018 Q1	2017 Q1
OPERATING ACTIVITIES
Net Income	$95.87M	$69.42M
YoY Change	38.1%	71.21%
Depreciation, Depletion And Amortization	$11.43M	$7.867M
YoY Change	45.34%	64.17%
Cash From Operating Activities	$77.33M	$47.62M
YoY Change	62.39%	55.22%
INVESTING ACTIVITIES
Capital Expenditures	$57.58M	$59.57M
YoY Change	-3.34%	194.79%
Acquisitions	$0.00	$8.953M
YoY Change	-100.0%
Other Investing Activities	-$462.0K	$850.0K
YoY Change	-154.35%
Cash From Investing Activities	$109.3M	-$148.5M
YoY Change	-173.6%	320.38%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$91.98M	-$3.495M
YoY Change	-2731.76%	-35.09%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$139.8M	-$33.00M
YoY Change	323.69%	262.41%
NET CHANGE
Cash From Operating Activities	$77.33M	$47.62M
Cash From Investing Activities	$109.3M	-$148.5M
Cash From Financing Activities	-$139.8M	-$33.00M
Net Change In Cash	$48.49M	-$131.4M
YoY Change	-136.9%	856.28%
FREE CASH FLOW
Cash From Operating Activities	$77.33M	$47.62M
Capital Expenditures	$57.58M	$59.57M
Free Cash Flow	$19.75M	-$11.95M
YoY Change	-265.33%	-214.08%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017Q4	algn	Allowance For Doubtful Accounts Receivable And Sales Returns Current AllowanceForDoubtfulAccountsReceivableAndSalesReturnsCurrent	5814000	USD
CY2018Q1	algn	Allowance For Doubtful Accounts Receivable And Sales Returns Current AllowanceForDoubtfulAccountsReceivableAndSalesReturnsCurrent	2735000	USD
CY2017Q4	algn	Capitalized Commissions CapitalizedCommissions	5515000	USD
CY2018Q1	algn	Capitalized Commissions CapitalizedCommissions	7681000	USD
CY2018Q1	algn	Accrued Sales And Marketing Current AccruedSalesAndMarketingCurrent	32458000	USD
CY2017Q4	algn	Accrued Sales And Marketing Current AccruedSalesAndMarketingCurrent	27318000	USD
CY2017Q4	algn	Accrued Sales Return Reserve Current AccruedSalesReturnReserveCurrent	1364000	USD
CY2018Q1	algn	Accrued Sales Return Reserve Current AccruedSalesReturnReserveCurrent	4887000	USD
CY2017Q4	algn	Accrued Fixed Assets Current AccruedFixedAssetsCurrent	11362000	USD
CY2018Q1	algn	Accrued Fixed Assets Current AccruedFixedAssetsCurrent	15241000	USD
CY2016Q4	algn	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	393019000	USD
CY2017Q1	algn	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	261607000	USD
CY2017Q4	algn	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	450125000	USD
CY2018Q1	algn	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	498619000	USD
CY2017Q1	algn	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-131412000	USD
CY2018Q1	algn	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	48494000	USD
CY2017	algn	Deferred Tax Liability Not Recognized Amount Of Unrecognized Deferred Tax Liability Undistributed Earnings Of Foreign Subsidiaries No Longer Indefinitely Reinvested DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiariesNoLongerIndefinitelyReinvested	591900000	USD
CY2017Q4	algn	Deferred Tax Liability Not Recognized Amount That Would Be Due If Earnings Are Distributed DeferredTaxLiabilityNotRecognizedAmountThatWouldBeDueIfEarningsAreDistributed	3300000	USD
CY2017Q4	algn	Equity Method Investments And Other Assets EquityMethodInvestmentsAndOtherAssets	43893000	USD
CY2018Q1	algn	Fair Value Measurementwith Unobservable Inputs Reconciliation Recurring Basis Asset Accrual FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisAssetAccrual	25000	USD
CY2017Q4	algn	Finite Lived Intangible Assets Accumulated Amortization Period Increase Decrease FiniteLivedIntangibleAssetsAccumulatedAmortizationPeriodIncreaseDecrease	24404000	USD
CY2018Q1	algn	Finite Lived Intangible Assets Accumulated Amortization Period Increase Decrease FiniteLivedIntangibleAssetsAccumulatedAmortizationPeriodIncreaseDecrease	25848000	USD
CY2017Q4	algn	Finite Lived Intangible Assets Accumulated Impairment Loss FiniteLivedIntangibleAssetsAccumulatedImpairmentLoss	19258000	USD
CY2018Q1	algn	Finite Lived Intangible Assets Accumulated Impairment Loss FiniteLivedIntangibleAssetsAccumulatedImpairmentLoss	19258000	USD
CY2018Q1	algn	Future Amortization Expense Thereafter FutureAmortizationExpenseThereafter	2435000	USD
CY2017	algn	Marketable Securities Weighted Average Remaining Maturity MarketableSecuritiesWeightedAverageRemainingMaturity	P6M
CY2018Q1	algn	Marketable Securities Weighted Average Remaining Maturity MarketableSecuritiesWeightedAverageRemainingMaturity	P5M
CY2018Q1	algn	Maturity Period Used To Classify Investments MaturityPeriodUsedToClassifyInvestments	P40M
CY2018Q1	algn	Operating Leases Future Minimum Payments Due Remainder Of Period OperatingLeasesFutureMinimumPaymentsDueRemainderOfPeriod	13508000	USD
CY2017Q4	algn	Other Longterm Assets OtherLongtermAssets	4821000	USD
CY2018Q1	algn	Other Longterm Assets OtherLongtermAssets	5831000	USD
CY2018Q1	algn	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	309000000	USD
CY2017Q4	algn	Tax Cuts And Jobs Act Of2017 Change In Tax Rate Income Tax Expense Benefit TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit	84300000	USD
CY2018Q1	algn	Tax Cuts And Jobs Act Of2017 Change In Tax Rate Income Tax Expense Benefit TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit	2400000	USD
CY2018Q1	dei	Amendment Flag AmendmentFlag	false
CY2018Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2018Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2018Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
CY2018Q1	dei	Document Period End Date DocumentPeriodEndDate	2018-03-31
CY2018Q1	dei	Document Type DocumentType	10-Q
CY2018Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001097149
CY2018Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	80149641	shares
CY2018Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2018Q1	dei	Entity Registrant Name EntityRegistrantName	ALIGN TECHNOLOGY INC
CY2018Q1	dei	Trading Symbol TradingSymbol	ALGN
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	36776000	USD
CY2018Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	41881000	USD
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	324189000	USD
CY2018Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	361459000	USD
CY2017Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	12405000	USD
CY2018Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	17134000	USD
CY2017Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	195562000	USD
CY2018Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	180093000	USD
CY2017Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	11209000	USD
CY2018Q1	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	5121000	USD
CY2017Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	6316000	USD
CY2018Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	6562000	USD
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	571000	USD
CY2018Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1484000	USD
CY2017Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	886435000	USD
CY2018Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	858632000	USD
CY2017Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	14812000	USD
CY2018Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	15830000	USD
CY2017Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1400000	USD
CY2018Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1400000	USD
CY2017Q4	us-gaap	Assets Assets	1784009000	USD
CY2018Q1	us-gaap	Assets Assets	1782731000	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	1158367000	USD
CY2018Q1	us-gaap	Assets Current AssetsCurrent	1168776000	USD
CY2017Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	311979000	USD
CY2018Q1	us-gaap	Available For Sale Securities AvailableForSaleSecurities	174952000	USD
CY2017Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	272031000	USD
CY2018Q1	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	164740000	USD
CY2017Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	272031000	USD
CY2018Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	164740000	USD
CY2017Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	39948000	USD
CY2018Q1	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	10212000	USD
CY2017Q4	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	39948000	USD
CY2018Q1	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	10212000	USD
CY2017Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	7662000	USD
CY2018Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	18739000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	449511000	USD
CY2018Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	498003000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-131412000	USD
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2018Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2018Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	80040000	shares
CY2018Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	80144000	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	80040000	shares
CY2018Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	80144000	shares
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	8000	USD
CY2018Q1	us-gaap	Common Stock Value CommonStockValue	8000	USD
CY2017Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	68976000	USD
CY2018Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	96779000	USD
CY2017Q1	us-gaap	Cost Of Revenue CostOfRevenue	74716000	USD
CY2018Q1	us-gaap	Cost Of Revenue CostOfRevenue	109516000	USD
CY2017Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	7789000	USD
CY2018Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	4069000	USD
CY2017Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	267713000	USD
CY2018Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	296011000	USD
CY2017Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	4588000	USD
CY2018Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	6171000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	49334000	USD
CY2018Q1	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	45524000	USD
CY2017Q4	us-gaap	Deferred Tax Liability Not Recognized Amount Of Unrecognized Deferred Tax Liability Undistributed Earnings Of Foreign Subsidiaries DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries	14700000	USD
CY2017Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	7867000	USD
CY2018Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	11434000	USD
CY2017Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.87
CY2018Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.20
CY2017Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.85
CY2018Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.17
CY2017Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	2430000	USD
CY2018Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	1715000	USD
CY2017Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.114
CY2018Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.029
CY2018Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2017Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	103004000	USD
CY2018Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	69581000	USD
CY2017Q4	us-gaap	Equity Method Investments EquityMethodInvestments	54600000	USD
CY2017Q4	us-gaap	Equity Method Investments EquityMethodInvestments	54606000	USD
CY2018Q1	us-gaap	Equity Method Investments EquityMethodInvestments	52829000	USD
CY2018Q1	us-gaap	Equity Method Investments EquityMethodInvestments	52800000	USD
CY2018Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1	358000	USD
CY2017Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	4476000	USD
CY2018Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	4859000	USD
CY2018Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	4843000	USD
CY2018Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	2116000	USD
CY2018Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	3389000	USD
CY2018Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	3882000	USD
CY2018Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	6343000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	68116000	USD
CY2018Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	68114000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	24454000	USD
CY2018Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	23008000	USD
CY2016	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2017Q1	us-gaap	Gross Profit GrossProfit	235625000	USD
CY2018Q1	us-gaap	Gross Profit GrossProfit	327408000	USD
CY2017Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	63318000	USD
CY2018Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	100545000	USD
CY2017Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1121000	USD
CY2018Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1777000	USD
CY2017Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-7223000	USD
CY2018Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2902000	USD
CY2017Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	5522000	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	5599000	USD
CY2017Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	24525000	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	36026000	USD
CY2017Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	1189000	USD
CY2018Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	5259000	USD
CY2017Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-40891000	USD
CY2018Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-35466000	USD
CY2017Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	11688000	USD
CY2018Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	28391000	USD
CY2017Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	7923000	USD
CY2018Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4002000	USD
CY2017Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	527000	USD
CY2018Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	15873000	USD
CY2017Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	89068000	USD
CY2018Q1	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	87629000	USD
CY2017Q1	us-gaap	Interest Income Operating InterestIncomeOperating	1195000	USD
CY2018Q1	us-gaap	Interest Income Operating InterestIncomeOperating	2176000	USD
CY2017Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	6810000	USD
CY2018Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	11038000	USD
CY2017Q4	us-gaap	Inventory Net InventoryNet	31688000	USD
CY2018Q1	us-gaap	Inventory Net InventoryNet	35866000	USD
CY2017Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	12721000	USD
CY2018Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	13386000	USD
CY2017Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	12157000	USD
CY2018Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	11442000	USD
CY2017Q4	us-gaap	Liabilities Liabilities	629721000	USD
CY2018Q1	us-gaap	Liabilities Liabilities	655271000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1784009000	USD
CY2018Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1782731000	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	500051000	USD
CY2018Q1	us-gaap	Liabilities Current LiabilitiesCurrent	517985000	USD
CY2018Q1	us-gaap	Line Of Credit LineOfCredit	0	USD
CY2013Q1	us-gaap	Line Of Credit Facility Current Borrowing Capacity LineOfCreditFacilityCurrentBorrowingCapacity	10000000	USD
CY2018Q1	us-gaap	Line Of Credit Facility Current Borrowing Capacity LineOfCreditFacilityCurrentBorrowingCapacity	50000000	USD
CY2013Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	50000000	USD
CY2018Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	200000000.0	USD
CY2017Q4	us-gaap	Loans Receivable Net LoansReceivableNet	30000000	USD
CY2018Q1	us-gaap	Loans Receivable Net LoansReceivableNet	0	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-33001000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-139822000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-148462000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	109269000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	47621000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	77332000	USD
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	69420000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	95866000	USD
CY2017Q4	us-gaap	Noncurrent Assets NoncurrentAssets	348793000	USD
CY2018Q1	us-gaap	Noncurrent Assets NoncurrentAssets	400528000	USD
CY2017Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	450000	USD
CY2018Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	177000	USD
CY2018Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2017Q1	us-gaap	Operating Expenses OperatingExpenses	173952000	USD
CY2018Q1	us-gaap	Operating Expenses OperatingExpenses	229216000	USD
CY2017Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	61673000	USD
CY2018Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	98192000	USD
CY2018Q1	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	66539000	USD
CY2018Q1	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	7107000	USD
CY2018Q1	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	9270000	USD
CY2018Q1	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	11056000	USD
CY2018Q1	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	15061000	USD
CY2018Q1	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	10537000	USD
CY2017Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	11152000	USD
CY2018Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	17112000	USD
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	43893000	USD
CY2018Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	17233000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	15000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-129000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-459000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1042000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-444000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	913000	USD
CY2017Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	15579000	USD
CY2018Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	17937000	USD
CY2017Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-2079000	USD
CY2018Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-474000	USD
CY2017Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	850000	USD
CY2018Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-462000	USD
CY2017Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	3793000	USD
CY2018Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	100000000	USD
CY2017Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	36496000	USD
CY2018Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	47842000	USD
CY2017Q1	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	169777000	USD
CY2018Q1	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	0	USD
CY2017Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	8953000	USD
CY2018Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2017Q1	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	8000000	USD
CY2018Q1	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	0	USD
CY2017Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	59569000	USD
CY2018Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	57578000	USD
CY2017Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2018Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2017Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2018Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2017Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2018Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	80948000	USD
CY2018Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	108708000	USD
CY2017Q1	us-gaap	Proceeds From Collection Of Loans Receivable ProceedsFromCollectionOfLoansReceivable	0	USD
CY2018Q1	us-gaap	Proceeds From Collection Of Loans Receivable ProceedsFromCollectionOfLoansReceivable	30000000	USD
CY2017Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	7288000	USD
CY2018Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	8020000	USD
CY2017Q1	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	87003000	USD
CY2018Q1	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	126825000	USD
CY2017Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	11684000	USD
CY2018Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	9560000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	348793000	USD
CY2018Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	400528000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	267274000	USD
CY2017Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	22804000	USD
CY2018Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	29591000	USD
CY2018Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	267336000	USD
CY2017Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	5503000	USD
CY2018Q1	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	5340000	USD
CY2017Q1	us-gaap	Sales Revenue Net SalesRevenueNet	310341000	USD
CY2018Q1	us-gaap	Sales Revenue Net SalesRevenueNet	436924000	USD
CY2017Q4	us-gaap	Security Deposit SecurityDeposit	3557000	USD
CY2018Q1	us-gaap	Security Deposit SecurityDeposit	3721000	USD
CY2017Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	151148000	USD
CY2018Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	199625000	USD
CY2017Q1	us-gaap	Share Based Compensation ShareBasedCompensation	14812000	USD
CY2018Q1	us-gaap	Share Based Compensation ShareBasedCompensation	15830000	USD
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.261
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.357
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.009
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.019
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	60000	shares
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	11.28
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	0	shares
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0.00
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	26.09
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	78.38
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	14369000	USD
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	75000	shares
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	60000	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	11.36
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	11.28
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	14369000	USD
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	60000	shares
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	11.28
CY2018Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	11.65
CY2017Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P1Y2M12D
CY2018Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P1Y3M18D
CY2018Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	14369000	USD
CY2018Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P9M22D
CY2018Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9M22D
CY2018Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P9M22D
CY2016Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	3841000	USD
CY2017Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	4301000	USD
CY2017Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	5929000	USD
CY2018Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	6657000	USD
CY2017Q4	us-gaap	Standard Product Warranty Accrual Current StandardProductWarrantyAccrualCurrent	5929000	USD
CY2018Q1	us-gaap	Standard Product Warranty Accrual Current StandardProductWarrantyAccrualCurrent	6657000	USD
CY2017Q1	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	1362000	USD
CY2018Q1	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	1631000	USD
CY2017Q1	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	1822000	USD
CY2018Q1	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	2359000	USD
CY2018Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	15000	shares
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	1154288000	USD
CY2018Q1	us-gaap	Stockholders Equity StockholdersEquity	1127460000	USD
CY2017Q4	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	114091000	USD
CY2018Q1	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	119349000	USD
CY2017Q4	us-gaap	Undistributed Earnings Of Foreign Subsidiaries UndistributedEarningsOfForeignSubsidiaries	606500000	USD
CY2017Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	47700000	USD
CY2018Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	50300000	USD
CY2018Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	3300000	USD
CY2018Q1	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	28000000	USD
CY2017Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1630000	shares
CY2018Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1592000	shares
CY2017Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	81534000	shares
CY2018Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	81628000	shares
CY2017Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	79904000	shares
CY2018Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	80036000	shares
CY2018Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;text-align:justify;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with generally accepted accounting principles (“GAAP”) in the U.S. requires our management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. On an ongoing basis, we evaluate our estimates, including those related to the fair values of financial instruments, long-lived assets and goodwill, equity method investments, useful lives of intangible assets and property and equipment, revenue recognition, stock-based compensation, income taxes and contingent liabilities, among others. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.</font></div></div>

Files In Submission

Name	View Source	Status
0001097149-18-000019-index-headers.html	Edgar Link	pending
0001097149-18-000019-index.html	Edgar Link	pending
0001097149-18-000019.txt	Edgar Link	pending
0001097149-18-000019-xbrl.zip	Edgar Link	pending
algn-20180331.htm	Edgar Link	pending
algn-20180331.xml	Edgar Link	completed
algn-20180331.xsd	Edgar Link	pending
algn-20180331xex311.htm	Edgar Link	pending
algn-20180331xex312.htm	Edgar Link	pending
algn-20180331xex321.htm	Edgar Link	pending
algn-20180331_cal.xml	Edgar Link	unprocessable
algn-20180331_def.xml	Edgar Link	unprocessable
algn-20180331_lab.xml	Edgar Link	unprocessable
algn-20180331_pre.xml	Edgar Link	unprocessable
chart-8022e3cf1db05df0900.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ALGN
ALIGN TECHNOLOGY INC Stock $algn

2018 Q1 Form 10-Q Financial Statement

#000109714918000019 Filed on May 03, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ALGN ALIGN TECHNOLOGY INC Stock $algn

2018 Q1 Form 10-Q Financial Statement

#000109714918000019 Filed on May 03, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ALGN
ALIGN TECHNOLOGY INC Stock $algn